Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Consumer October 16, 2026 — Counterfeit versions of over-the-counter eye drops have been found in Florida and Georgia in stores serving primarily Spanish-speaking customers. These products also may be in Louisiana, Mississippi, North…
- Audience: Health Care Professional, Consumer ROCHESTER, MI– October 13, 2026 – Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the…
- Audience: Health Care Professional, Consumer ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is…
- Audience: Health Care Professional, Consumer October 6, 2026 — The FDA Adverse Event Reporting System (FAERS) has received increased reporting of allergic/hypersensitivity type reactions following infusion of a specific lot of Immune Globulin…
- Audience: Health Care Professional, Consumer Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being…
New Drug Approvals
- Philadelphia, PA — October 19 2026 — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as the first and only immunotherapy for adults with stage II and III microsatellite…
- South San Francisco, CA — October 15, 2026 — Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab-mwge) for the treatment of…
- Brussels, Belgium and Atlanta, Georgia – October 16, 2026 – UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first self-administered…
- GENEVA–(BUSINESS WIRE) October 16, 2026 — Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved Brytly® Redness Reliever…
- PITTSBURGH, Oct. 16, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of…
New Drug Applications
- WARREN, N.J., Oct. 15, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful improvement to patients' lives…
- FORT LEE, N.J., Oct. 14 – Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients with cancer, today…
- THOUSAND OAKS, Calif.–(BUSINESS WIRE) October 14, 2026 — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for…
- BAGSVÆRD, Denmark, Oct. 02, 2026 — Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and…
- DEL MAR, CALIF., USA — September 30, 2026 — The US Food and Drug Administration has accepted CeleCor Therapeutics’ New Drug Application (NDA) for zalunfiban (DisaggproTM) and assigned a target action date of June 18, 2027 under the…
Clinical Trial Results
- PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Oct. 20, 2026 /PRNewswire/ — Today, Novo announced results from two post hoc analyses of the REDEFINE 1 trial presented at The Menopause Society 2026 Annual Meeting in San Diego. In an analysis of…
- NORTH CHICAGO, Ill., Oct. 19, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that its investigational ABBV-466, a novel dual-targeting therapy against IL-23 p19 and integrin α4β7, demonstrated higher rates of endoscopic…
- CAMBRIDGE, Mass., Oct. 15, 2026 /PRNewswire/ — Marengo Therapeutics Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation and immunology (I&I), today announced that the U.S. Food and…
- October 14, 2026 — In a National Institutes of Health (NIH)-funded study, scientists have demonstrated that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism…
- MIAMI, Oct. 13, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases…
Daily Med News
- TUESDAY, Oct. 20, 2026 — Antibiotic use during childhood may be linked to an increased risk of irritable bowel syndrome, or IBS. IBS is a common digestive disorder that causes symptoms such as abdominal pain and changes in bowel…
- TUESDAY, Oct. 20, 2026 — Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for certain…
- TUESDAY, Oct. 20, 2026 — Obesity is a long-term health challenge that many people face. In fact, the World Health Organization has declared obesity a global epidemic. For some, healthy eating and regular exercise are enough to lose weight…
- TUESDAY, Oct. 20, 2026 — Older women might want to think twice before taking testosterone to treat their lagging libido, a new study says. Testosterone therapy appears to increase a woman’s risk of heart attack, stroke and other heart…
- TUESDAY, Oct. 20, 2026 — Patients with a spinal cord injury can use everyday exercise to reduce their chronic pain, a new study says. Spinal cord patients reported that their chronic nerve or muscle pain eased after they followed an…
News for Health Professionals
- TUESDAY, Oct. 20, 2026 — For women with breast cancer, survival is inferior in rural areas, and decreases in mortality rates are slower in rural areas for cancers amenable to early detection, according to two studies presented at the annual…
- TUESDAY, Oct. 20, 2026 — Enzyme-inducing antiseizure drugs (ASDs) are associated with increased odds of incident osteoporosis or osteopenia, but vitamin D supplementation is underutilized, according to a study presented at the annual meeting of the…
- TUESDAY, Oct. 20, 2026 — Children living in areas with higher levels of lithium in drinking water are more likely to be diagnosed with Wolff-Parkinson-White (WPW) syndrome, according to a study published online Oct. 13 in the Journal of Clinical…
- TUESDAY, Oct. 20, 2026 — For living kidney donors, cigarette smoking is associated with an increased risk for all-cause graft loss, according to a study published online Oct. 1 in Kidney360. Machi Kaneko McBee, M.D., from the University of…
- TUESDAY, Oct. 20, 2026 — Antibiotic use from preadolescence through early adulthood is associated with an increased risk for irritable bowel syndrome (IBS), according to a study presented at UEG Week, the annual meeting of United European…
